Make sure not to miss this valuable item your first time around. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on ...

EL SUNZAL, La Libertad, El Salvador (FOX 5/KUSI) — San Clemente’s Rachael Tilly was crowned the 2025 World Longboard Champion at the Surf City El Salvador Longboard Championships on Nov. 6, defending ...

Longboarding isn’t often associated with aggressive adjectives, but Rachael Tilly’s performance on Thursday at El Salvador’s El Sunzal was, to put it mildly, a rampage. Ten years after winning her ...

View post: Global Cancer Rates Have Doubled Since 1990, and a New Study Says the World Isn’t Ready View post: How Many Seasons Will HBO Max's 'The Pitt' Have? Show Star and Creator Drop a Big Hint ...

Longboards plans Meridian expansion, with construction aiming to be done in March 2026. Restaurant combines pizza, wings and self-serve frozen yogurt in one venue. Menu offers Detroit-style and ...

Whether one likes to surf or just watch those out catching a wave, Tourmaline Surf Park will be the place to do all that when the 25th annual Summer Longboard Classic returns on June 14. Hosted by the ...

Antonia Haynes is a Game Rant writer who resides in a small seaside town in England where she has lived her whole life. Beginning her video game writing career in 2014, and having an avid love of ...

In a significant corporate development, Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) has finalized its acquisition by H. Lundbeck A/S, a Danish pharmaceutical firm, as of Monday. This transaction ...

Two Southern California surfers have claimed the 2024 World Surf League’s World Longboard Championship – a second win for Dana Point native Rachael Tilly and a fourth for San Diego’s Taylor Jensen.

Longboard Pharmaceuticals LBPH announced that it is set to be acquired by Lundbeck A/S for $60 per share in cash, which brings the total deal value to $2.6 billion equity value and $2.5 billion ...

Lundbeck announced this week that it will acquire Longboard Pharmaceuticals in a $2.6 billion deal, picking up the epilepsy drug bexicaserin in the process. The move — the largest to date for the ...